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Abstract
Chromosomal instability (CIN) plays a crucial role in tumor development and occurs mainly as the consequence of either
missegregation of normal chromosomes (MSG) or structural rearrangement (SR). However, little is known about the
respective chromosomal targets of MSG and SR and the way these processes combined within tumors to generate CIN. To
address these questions, we karyotyped a consecutive series of 96 near-diploid colorectal cancers (CRCs) and distinguished
chromosomal changes generated by either MSG or SR in tumor cells. Eighty-three tumors (86%) presented with
chromosomal abnormalities that contained both MSGs and SRs to varying degrees whereas all 13 others (14%) showed
normal karyotype. Using a maximum likelihood statistical method, chromosomes affected by MSG or SR and likely to
represent changes that are selected for during tumor progression were found to be different and mostly mutually exclusive.
MSGs and SRs were not randomly associated within tumors, delineating two major pathways of chromosome alterations
that consisted of either chromosome gains by MSG or chromosomal losses by both MSG and SR. CRCs showing
microsatellite instability (MSI) presented with either normal karyotype or chromosome gains whereas MSS (microsatellite
stable) CRCs exhibited a combination of the two pathways. Taken together, these data provide new insights into the
respective involvement of MSG and SR in near-diploid colorectal cancers, showing how these processes target distinct
portions of the genome and result in specific patterns of chromosomal changes according to MSI status.
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Introduction
It has been demonstrated that chromosomes display non-
random changes in cancer cells. These include structural
rearrangements (SRs), e.g. deletions, amplifications or transloca-
tions that arise from breaks in DNA, as well as alterations in the
number of intact chromosomes, known as whole-chromosome
missegregations (MSGs), originating from errors in cell division
(mitosis). As a result of the accumulation of such processes,
chromosomal instability (CIN) is known to play a key role in tumor
development. However, little is known about the exact contribu-
tion of MSG and SR in CIN and whether they act synergistically
during tumor progression. Although chromosomal rearrangement
is a well-documented process associated with tumorigenesis, the
contribution of whole-chromosome aneuploidy to tumor develop-
ment is still the subject of controversy. Colorectal cancers (CRCs)
have been classified into two major molecular subtypes: CIN and
MSI (for ‘‘microsatellite instability’’, also called MIN). MSI CRCs
account for approximately 15–20% of sporadic colorectal cancers.
It is a well-defined subtype that results from a loss of DNA
mismatch repair (MMR) function, secondary to inactivation of
MMR genes. By failing to repair spontaneous errors that occur
during replication, these tumors accumulate frameshift mutations
that affect tumor suppressor genes containing coding repeat
sequences [1]. MSI tumors are believed to be near-diploid with
few, if any, karyotypic abnormalities. Conversely, CIN was found
to occur in non-MSI cancers (or MSS for ‘‘microsatellite stable’’)
that represent the great majority of CRCs and are proficient for
mismatch repair. Although observed in about 80% of sporadic
colorectal tumors, the CIN phenotype is more poorly defined than
MSI. Originally used to describe tumors that display a high degree
of intercellular heterogeneity in chromosome number, ascertained
by counts for a restricted set of chromosome-specific centromeres
[2], CIN was further employed to describe cancers with either
aneuploid or polyploid DNA content as measured by cytometry or
cytogenetics, or multiple gains or deletions of chromosomes or
chromosome arms, or frequent losses of heterozygosity (LOH). At
present, there is no consensus for the experimental approach to be
used or the minimum rate of chromosomal instability required to
define CIN tumors. This results in much current confusion in the
literature regarding the relationship between MSI and CIN
following the method used to estimate CIN in such CRCs.
Although MSI and CIN were considered mutually exclusive, both
our previous data and recent studies suggest that some MSI
tumors may also show evidence of CIN, although the extent and
nature of this overlap remains to be determined [3–8].
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comparison to molecular studies allows to easily distinguish MSGs
from SRs. Here, we used this approach to more precisely
characterize CIN in a consecutive series of 96 near-diploid
colorectal primary tumors that were prospectively collected over a
10 year period. Near-diploid tumors were chosen because of the
ambiguity involved in determining gains and losses in polyploid
tumors that have undergone endoreduplication. Indeed, interpre-
tation of all numerical chromosome changes observed in a triploid
tumor for instance, is totally different whether such tumor is
considered as a diploid tumor that has gained many chromosomes
or that has undergone endoreduplication with further subsequent
chromosome losses to reach triploidy. In the present work, near-
diploid CRCs were defined as those with a number of
chromosomes between 35 and 57, according to the International
System for Cytogenetic Nomenclature [9]. They constitute 50.2%
of our initial series of karyotyped CRCs (data not shown), which is
consistent with prior studies that have shown the diploid fraction
of CRCs to be around 40% ([10], for review). We investigated in
detail the nature and targets of CIN in these tumors. By
distinguishing chromosomal changes generated by MSG or SR,
we were able to compile a list of chromosomes or chromosomal
regions targeted by MSG and SR and to study how these processes
were associated within tumors in generating CIN. We also looked
for differences in the nature of CIN between MSI and MSS
subtypes of CRC. New insights concerning the role of CIN in
CRC were obtained that allowed us to propose a new perspective
on carcinogenesis in near-diploid CRCs which takes into account
both their cytogenetic and molecular features.
Results
Missegregations and structural rearrangements of
chromosomes target distinct portions of the tumor
genome in near-diploid CRCs
A series of 96 near-diploid colorectal tumors were analyzed
among which 13 cases showed a normal karyotype. The total
number of whole-chromosome gains was comparable to that of
whole-chromosome losses (224 and 189 respectively, Chi2=2.96,
p=0.10). Whole-chromosome gains and losses involving individ-
ual chromosomes (Supplementary Table S2) were pooled and the
distribution of missegregated chromosomes was tested using a
likelihood statistical modeling. Frequencies of missegregation for
individual chromosomes ranged from 0–54% (Figure 1A). The
highest likelihood was observed for two groups containing 12
chromosomes each, with p1=0.42, p2=0.13 and alpha=0.46.
The first group comprised, by decreasing frequency of missegrega-
tion, chromosomes 18, 20, Y, 13, 7, X, 12, 14, 15, 8, 4 and 6. This
group is likely to represent target chromosomes whose missegrega-
tion is selected for during tumor evolution. For most of these
chromosomes, a clear tendency was observed towards either gain
(chromosomes 7, 12, 13, 20 and X) or loss (chromosomes 4, 14, 15,
18 and Y) (Figure 1B). The second group is likely to represent the
background of chromosomal instability occurring by MSG in
colorectal tumors. The same approach was applied for chromo-
somes involved in structural rearrangements. Frequencies of
rearrangements for individual chromosomes ranged from 0–
42.7% (Figure 1C). The likelihood statistical modeling (p1=0.38,
p2=0.07, alpha=0.58) suggests that among the chromosomes
involved in SRs, only chromosomes 17, 1, 8, 13, 6, 5, 11, 10, 9 and
4 are likely to represent target chromosomes that are selected for
during tumor progression. For all of these chromosomes except 4,
9 and 11, a clear tendency was observed towards either
chromosome arm gain (8q, 13q and 17q) or loss (1p, 5q, 6q, 8p,
10q and 17p) (Figure 1D). Among the total imbalances resulting
from SRs, deletions were twice more frequent than gains (197 versus
101, respectively, Chi2=30.92, p,0.001, see Supplementary Table
S3). A compilation of the chromosomal targets for MSG and SR is
represented on Figure 2. Except for chromosomes 4, 6, 8 and 13,
these weremutually exclusive (chromosomes 7, 12, 14, 15, 18,20,X,
Y for MSG compared to chromosomes 1, 5, 9, 10, 11, 17 for SR),
highlighting the fact that these processes mainly target distinct
portions of the tumor genome in near-diploid CRCs.
Evidence for preferential associations among
chromosome alterations
The total number of missegregated chromosomes per tumor
ranged from 0–14 (mean=4.5363.08) and that of rearranged
chromosomes from 0–15 (mean=4.4463.66). Using linear correla-
tion analyses on the 83 tumors presenting an abnormal karyotype,
the number of rearranged chromosomes was found not to be
correlated with missegregation events within tumors (r=0.20,
p=0.07). When whole-chromosome gains and losses were distin-
guished, the number of whole-chromosome gains and rearranged
chromosomes was inversely correlated (r=20.31, p=0.004),
whereas the increase in the number of whole-chromosome losses
paralleledthatofrearrangedchromosomes(r=0.69,p=4.0710
213).
We next investigated for possible preferential associations
amongst the most frequent chromosome imbalances generated
by either MSG or SR, i.e. those that were likely to be selected for
in CRCs according to the likelihood method. A systematic analysis
of two-by-two associations between 29 chromosomal imbalances
(406 possibilities) demonstrated 51 associations (45 positive and 6
negative) that were significant in our tumor series (p=0.05)
(Supplementary Table S4). We are aware that considering that
406 analyses were performed, it could be expected that 20 out of
these 51 significant associations were observed by chance alone
(false positive) at the p=0.05 level. Using a p=0.01 level, 16
significant associations were found (Figure 3) that is four times
more than the number of false positive expected, validating thus
the existence of preferential associations. A p=0.05 level was
retained for the analysis. Amongst the 45 positive associations,
most (84%) involved exclusively losses or gains (27 and 11,
respectively) compared to 7 that showed gains mixed with losses
(16%). Twenty (44.5%) showed associations of MSG with SR
events compared to 15 (33.3%) and 10 (22.2%) that involved
exclusively MSGs or SRs, respectively. By combining all results
from two-by-two associations of chromosomal alterations observed
in CRCs, two main groups of chromosomal abnormalities were
delineated (Figure 3). The first group includes only whole-
chromosome gains resulting from MSG (+13, +20, +7, +X, +12
and +6) whereas the second group mainly consists of chromosomal
losses through MSG and SR (-18, -17p, -Y, -1p3, -8p, +8q, -14,
+13q, -15, -4, +17q, +8, +6, -10q2, -11q, -9p, -8, -4p, -11p, -9q
and -6, in decreasing order of occurrence). One minor group not
related to the former two groups consisted of a preferential
association between -4q and -5q.
CIN according to MSI in colorectal cancers
The MSI status of 66 tumors, determined according to
international criteria, showed 20 MSI and 46 MSS CRCs. Given
that MSI tumors are known to be near-diploid CRCs, it resulted in
an enrichment of MSI cases in our patients cohort that is restricted
to near-diploid CRCs (30% i.e. 20/66 compared to the expected
incidence of 15–20% in overall CRCs). This allowed us to obtain a
consequent series of MSI tumors in order to compare their
cytogenetic features to that of the most frequent MSS subtype.
Clinicopathological characteristics of the tumors are presented in
CIN in Colorectal Cancers
PLoS ONE | www.plosone.org 2 February 2008 | Volume 3 | Issue 2 | e1632Table 1 and Supplementary Table S1. All variables except tumor
location were equally distributed in the two subsets. Among the 10
tumors with normal karyotype whose MSI status was determined,
7 were MSI, confirming a high frequency of MSI in non-CIN
CRCs. Global comparisons between MSS and MSI tumors
showed that the latter group stayed very close to diploidy and
exhibited significantly less MSGs (mean of 1.45 versus 5.82 for
MSS tumors, p=3610
210) and SRs (mean 1.30 versus 5.02 for
MSS tumors, p=1.2610
26) (Table 1). Of note, the few observed
missegregations mainly consisted of whole-chromosome gains with
very rare whole-chromosome losses whereas MSS tumors
presented with more complex CIN including both MSG and SR
leading to combined gains and losses of chromosomal material.
Balanced rearrangements were relatively rare but did not
significantly differ between MSI and MSS CRCs (Table 1).
Classification of CRCs
Despite the existence of preferential two-by-two associations for
some chromosomal alterations, we failed to observe a classification
of tumors into different groups using unsupervised hierarchical
cluster analysis based on chromosomal alterations with a
significant confidence interval (bootstrap stimulation technique).
This argues for the absence of available criteria delineating
different subsets of near-diploid CRCs according to CIN.
Discussion
Unlike some haematopoietic tumors or sarcomas, carcinomas
are not characterized by translocation events that fuse an
oncogene to an inappropriate promoter. Indeed in most
epitheliomas, chromosomal instability proceeds through two major
mechanisms, missegregation that results in aneuploidy through the
gain or loss of whole-chromosomes, and unbalanced structural
rearrangements (unbalanced translocations, deletions, isochromo-
somes, …) that lead to the loss and/or gain of chromosomal
regions. We analyzed here a large series of near-diploid colorectal
cancers by classical cytogenetics to distinguish chromosomal
imbalances resulting from these two mechanisms. The use of the
likelihood statistical modeling helped to define chromosome
alterations that are likely to be selected for during tumor evolution
and thus rise above the background of chromosomal instability.
The outstanding features are that missegregation and structural
rearrangements lead to chromosomal imbalances that are mostly
mutually exclusive and combine to generate CIN in almost all
Figure 1. Involvement of chromosomes in missegregations (MSG) and structural rearrangements (SR) in our series of 96 near-
diploid colorectal tumors. Frequencies of MSG (A) with their resulting gains and losses (B) and frequencies of SR (C) with their resulting gains and
losses (D) are represented. The dotted line represents the cut-off value indicated by the likelihood statistical modeling that discriminates
chromosomes that are likely to be selected for during tumor progression (red) from those constituting the background of chromosomal instability
(grey). In B and D, each bar represents the percentage of loss (lower) or gain (upper) of a chromosome (B) or chromosome arm (D, p arm first, then q
arm for non-acrocentric chromosomes).
doi:10.1371/journal.pone.0001632.g001
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by MSG and SRs might have complementary rather than additive
effects in CRCs.
The overall pattern of chromosomal imbalances we observed in
near-diploid CRCs is consistent with previous reports that used
other approaches such as CGH for the genome-wide assessment of
DNA copy number in colorectal cancers (for review see [11]).
However, the questions of how missegregations and rearrange-
ments are distributed and how alterations are associated within
tumors have rarely been addressed [12,13]. Our data show that
structural rearrangements accumulate concurrently with whole-
chromosome losses during the progression of near-diploid CRCs.
In contrast, whole-chromosome gains and rearrangements, are
inversely correlated. Overall, preferential associations are found to
delineate two pathways of chromosome alterations that favored
the accumulation of either chromosomal losses or chromosome
gains in colorectal tumor cells and that are not mutually exclusive.
Of interest, MSG and SR highly cooperate in the pathway of
chromosomal losses that is associated with the so-called LOH
pathway since it leads to frequent chromosomal losses of the same
loci as those identified by LOH in CRCs, e.g. 17p, 18 and others
that contain tumor suppressor genes. In the other pathway, CIN
leads exclusively to the accumulation of whole-chromosome gains
through a missegregation process involving recurrently gains of
chromosomes 20, 13, 7, X, 12 and 6. Negative associations for
some imbalances are also observed (+12 and -15, +12 and -17p,
and +6 and -1p) suggesting that combination of such abnormalities
would be deleterious for tumor cells. All together, these data give a
new insight on the way MSG and SR combine during the
progression of near-diploid CRCs, suggesting that association of
chromosomal imbalances rather than isolated chromosomal
alterations would be of functional significance in this process.
Since microsatellite instabilityhas been described as an alternative
mechanism for colorectal cells to become malignant, we also
compared cytogeneticalterationsinnear-diploidCRCsinrelationto
their microsatellite status. As expected, MSI tumors were preferen-
tially located in the proximal colon. Interestingly, losses of whole-
chromosomes were very rare in MSI CRCs and a net tendency for
whole-chromosome gains was observed. Our data are consistent
with some previous observations reporting that chromosome gains
constitute a frequent feature of MSI CRCs. Indeed, early studies
from our group using karyotyping demonstrated on a small sample
of tumors that MSI CRCs displayed either a normal karyotype or
chromosome gains with no or few rearrangements [3]. Subsequent
studies on larger series of MSI tumors analyzed using chromosome
comparative genomic hybridization (CGH) or array-based CGH
(aCGH) have reported that gains of chromosomes and/or
chromosome arms constitute the more frequent chromosome
imbalances in MSI CRCs [4,6–8]. However in a number of papers,
MSI and CIN are considered to be mostly mutually exclusive. It is
worth noting that in these papers, CIN has been estimated through
LOH analysis. Indeed, since the early study of Thibodeau [14],
several reports demonstrated that LOH events were rarely found in
MSI CRCs ([15–18] for instance). Of interest, cytogenetics is a
morphological approach suitable for the detection of both
chromosomal gains and losses that are associated with CIN. Using
this method, we report here mostly chromosomal gains and only few
chromosomal losses in MSI CRCs, and conclude that such tumors
are indeed CIN+ in most of cases (65%). It can therefore be assumed
that the contradictory results that have been obtained following the
useofLOHanalysisarelikelytobeattributable,atleastinpart,toan
inaccurate assessment of CIN in these studies. A larger series of MSI
CRCs should now be analyzed in order to precise the most frequent
chromosomal gains observed in these tumors. However, the
coexistence of CIN and MSI should not be taken as the norm,
especially since of 20 MSI tumors in our series, 7 (35%) exhibited a
strictly normal karyotype.
Conversely to MSI CRCs that presented with a normal
chromosome complement or mainly with chromosome gains,
combinations of the two chromosomal pathways described above
(chromosomal gains and losses) were found in MSS CRCs. Lastly,
we found a subset of near-diploid MSS tumors that is
microsatellite and chromosomal stable consistent with previous
reports [4,5,16,19–22]. Taking into account that 3 supplementary
tumors with normal karyotype were of unknown microsatellite
status, it could be expected that such a subset of tumors neither
MSI nor CIN would constitute only a minor fraction of near-
diploid CRCs i.e. 3 (3/96) to 6% (6/96) and thus maybe less than
3% of all CRCs. Although 13 out of 96 tumors in our series do not
display chromosomal instability, it remains to be confirmed
whether or not they are associated with LOH through cryptic
mechanisms such as uniparental disomy or mitotic recombination.
CIN thus appears to play a role in both MSI and MSS colorectal
tumors, but alternative patterns of chromosomal events might be
selected for in near-diploid CRCs according to the presence or
absence of MSI. Despite these observations, unsupervised hierar-
chical cluster analysis performed in our series was unable to separate
tumors on the basis of chromosomal alterations. This discordance
Figure 2. Most relevant chromosomal targets for missegrega-
tion (MSG) and structural rearrangements (SR) are mutually
exclusive. Among the chromosomes or chromosome arms that are
likely to be selected for during tumor progression according the
likelihood modeling (see Figures 1B and 1D), only those for which a
significative tendency towards either gain or loss were retained (Chi2
test, under the null hypothesis, the numbers of gains and losses should
be distributed uniformly). Chromosomal losses (blue background) and
gains (red background) are distinguished.
doi:10.1371/journal.pone.0001632.g002
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smaller number oftumorsintheirstudy(46 cases)and tothe factthat
these authors did not test the confidence of their cluster analysis
results. It is consistent with the finding of no specific alterations for
MSI tumors, the most recurrent gains in MSI tumors being also
observed in MSS tumors.
The issue of the biological consequences of the non-random
imbalances observed in colorectal carcinomas is still debated. It is
generally considered that chromosomal losses confer an improved
likelihood of inactivating tumor suppressor genes. However,
current models of tumorigenesis generally fail to include a possible
role for chromosome gains. More generally, chromosomal
instability could provide a growth advantage to the cancer cell
by causing extensive changes in gene expression via increased cell
proliferation or decreased cell death. However, because of
transcriptional regulation, the relationship between DNA copy
number changes and perturbations in gene expression could be
more complex than a simple dosage effect. Interestingly, Tsafrir et
al. [23] recently demonstrated that expression of large groups of
contiguous genes in MSS colorectal carcinomas varies in a
coordinated way and reflects gain or loss of the corresponding
chromosomal segment. Based on the differences we observed
between MSS and MSI tumors, a putative model for carcinogen-
esis was proposed. It can be hypothesized that in MSS near-
diploid tumors, combination of the pathway of chromosome gains
with that of chromosomal losses is necessary to target both
oncogenes surexpression and tumor suppressor genes inactivation
respectively, whereas in MSI tumors, the observed gains of
chromosomes likely result in an increased expression of putative
oncogenes that would be complementary to the loss of function
frameshift mutational events that affects tumor suppressor genes
containing coding repeat sequences (Figure 4).
It is known that MSI CRCs stay near-diploid while a subset of
MSS CRCs become polyploid, possibly through an endoredupli-
cation process [24]. As already mentioned, polyploid CRCs could
not be included in our analysis because of the ambiguity to
distinguish chromosomal gains from losses in such CRCs.
Nevertheless, it is noteworthy that our cytogenetic data on the
subset of near-diploid CRCs are in agreement with the CGH
profile from a meta-analysis comprising a total of 859 CRCs of all
ploidy levels [11]. It has also to be noticed that our study cohort of
patients is biased in terms of inclusion of familial cases. As stated in
the supplementary table S1, 3 out of 96 patients with CRCs were
identified as patients with familial adenomatous polyposis, so that
it is unlikely that inclusion of these patients could have biased the
overall results. Since there was neither family history data of the
patients nor germline mutation screening for MLH1 or MSH2, it
is likely that some individuals with an early onset MSI CRC
enrolled in this study harbored hereditary non polyposis tumors.
Even if cytogenetic data associated with MSI CRCs of either early
(age #50 years at the time of surgery) or late onset (age .50 years)
were here found to be quite similar with notably no significant
difference concerning the number of tumors showing a normal
karyotype (see supplementary tables S1, S2 and S3), it would be of
interest to further investigate patients with familial CRCs
identified on the basis of rigorous criteria.
The morphological approach we used to analyze the chromo-
somal instability in near-diploid colorectal carcinomas highlights
the involvement of missegregative events affecting normal
chromosomes, especially chromosome gains, in colorectal carci-
nogenesis. Our work is highly suggestive of an involvement of
aneuploidy in CRCs through the selection of missegregation
events that cooperate with other events generated in these tumors
through chromosomal rearrangements or microsatellite instability.
Figure 3. The two major chromosomal pathways in near-diploid CRCs. Schematic representation of the two-by-two association study
presented in Supplementary Table S4. Positive (continuous lines) and negative (dotted lines) associations are represented by thick and thin lines
indicating significant associations at p=0.01 and 0.05 level, respectively. The size of each box is proportional to the frequency of the alteration,
whole-chromosome or chromosome arm gains (red background), and chromosome losses or deletions (blue background) being distinguished. The
preferential associations between alterations involving both arms of the same chromosome, such as -8p and +8q, or -17p and +17q, need to be
interpreted with caution since they originate mostly from a single isochromosome formation event. For instance, gain of 17q seems to be a side
effect of 17p deletion via isochromosome 17q formation (10/11 tumors with 17q gain also exhibited 17p loss whereas 17p loss alone was observed in
an additional 30 tumors) whereas both 8p loss and 8q gain might provide tumor cells with a selective advantage since although associated in 20
tumors, these alterations were also observed independently in 8 and 7 tumors, respectively (see also Supplementary Figure S1). Some negative
associations (between +13 and +13q, +8 and +8q, +8 and -8p) could also be due to the fact they involve the same chromosome.
doi:10.1371/journal.pone.0001632.g003
CIN in Colorectal Cancers
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es are now necessary to precise the functional consequences of the
genomic pathways we have characterized here, taking into
account the other molecular characteristics of CRCs.
Materials and Methods
Tumor specimens
Data were collected in the course of a systematic cytogenetic
analysis of colorectal cancers operated at the Curie Institute, Paris.
For the present study, we selected near-diploid tumors, that is with
a mean number of chromosomes between 35 and 57 according to
international criteria [9]. We used 96 tumors arising from 94
patients, with two patients having metachronous tumors. Three
patients presented with typical syndrome of familial adenomatous
polyposis. Because there was neither family history data of the
patients nor germline mutation screening for MLH1 or MSH2, we
cannot exclude the presence of hereditary non polyposis colorectal
cancer in our series of tumors. Clinicopathological characteristics
of patient age and sex, tumor location and Astler Coller staging are
provided in Supplementary Table S1.
Cytogenetic analysis
Cytogenetic analysis was performed on fresh tumors after surgery
for most cases or on endoscopic biopsies in some instances according
to our usual protocol [12]. Mechanical disaggregating of tissue was
performed and short-term culture for 24–48 h was achieved in TC
199 medium supplemented with 20% of human serum and
antibiotics. Cultures were harvested by a thymidine synchronization
method in most instances. Thymidine was added to the culture
medium at a final concentration of 0.3 mg/ml. After 17 hours, the
culture medium was removed, cells were washed twice and
incubated in fresh medium for 8 hours including a 3-hour treatment
with colcemid. Cells were fixed and spread on glass slides and
analysiswascarried out onkaryotypedcells afterR-banding.Inmost
tumors, cells with closely related abnormal chromosome comple-
ments were observed. Cells were considered as a clone when at least
two had the same structural aberration or trisomy, or at least three
had the same monosomy [9]. Comparison of clones led to the
reconstruction of the chromosomal evolution of the tumor [25].
Only chromosome aberrations observed in clones and subclones
were considered. Involvement of individual chromosomes in
missegregation and rearrangements were scored separately, together
with their resulting chromosomal imbalances (Supplementary
Tables S2 and S3). Detailed information on structural abnormalities
defined by band or sub-band is also provided (Supplementary Figure
S1). Many rearrangements led to whole-arm imbalances. However,
even for the rearrangements that resulted in loss or gain of only part
of the arm,the chromosome arm was noted as imbalanced. For each
tumor, the number of established karyotypes, the mean number of
chromosomes, the number of balanced rearrangements and that of
rearranged chromosomes and missegregations were recorded
(Supplementary Tables S1, S2 and S3). In all the text we refer to
missegregation as that of normal chromosomes.
Determination of MSI status
MSI status was determined using pentaplex PCR or immunohis-
tochemistry according to the material available. MSI determination
was carried out using a modified version of the pentaplex PCR [26]
inordertoavoidthe possibilityofinterference between differentdyes
Figure 4. The role of chromosomal instability in near-diploid
colorectal tumors according to MSI status. In MSS tumors,
combination of the pathway of chromosome gains with that of
chromosomal losses is necessary to target both oncogenes (ONC) and
tumor suppressor genes (TSG), respectively. In MSI tumors, the pathway
of chromosome gains is frequently observed whereas that of
chromosomal losses is rarely found. In these tumors however, loss of
function events are frequently observed as the consequence of
frameshift mutations in coding microsatellite sequences. MSG, misse-
gregation; SR, structural rearrangements.
doi:10.1371/journal.pone.0001632.g004
Table 1. Comparison of MSI and MSS tumors:
clinicopathological characteristics and frequency of
chromosome alterations.
MSS tumors MSI tumors p
Number of tumors 46 20
Gender of the patient
female 28 16 0.2*
male 18 4
Mean age of the patient 65.65 (10.47) 62.75 (18.93) 0.5
Location of the tumor
proximal 7 17 3.4 10
27 *
distal 13 2
rectum 26 1
Astler Coller’s stage of the tumor
A 2 0 0.36 *
B1 8 1 0
C1 3 8
D9 2
undetermined 4 0
Mean number of chromosomes
(SD)
48.07 (4.25) 46.65 (0.88) 0.03
Mean number of
missegregations (SD)
5.82 (3.06) 1.45 (1.67) 31 0
210
whole-chromosome losses 2.08 (2.24) 0.35 (0.81) 2.04 10
25
whole-chromosome gains 3.74 (3.40) 1.10 (1.59) 61 0
25
Mean number of rearranged
chromosomes (SD)
5.02 (3.71) 1.30 (1.89) 1.2 10
26
Mean number of balanced
rearrangements (SD)
0.41 (0.72) 0.3 (0.57) 0.50
All mean values are indicated with the standard deviation of the mean (SD).
Comparisons were performed using Student t test or Chi2 (*).
doi:10.1371/journal.pone.0001632.t001
CIN in Colorectal Cancers
PLoS ONE | www.plosone.org 6 February 2008 | Volume 3 | Issue 2 | e1632during laser scanning. Primers were redesigned and shifted so that
each amplification product would have a size differing by at least
20 bp from the others [27]. The five markers were co-amplified in a
standardmultiplex PCR with an annealing temperature of55uCa n d
were analyzed on an ABI PRISM 3100 Genetic Analyser according
to manufacturer’s instructions. Immunohistochemistry was per-
formed as described [28] using mouse anti-human antibodies to
MLH1 (dilution 1:100, clone G168-728, Pharmingen, San Diego
Calif., USA), MSH2 (dilution 1:125, clone FE11, Calbiochem,
Oncogene Research Products, Cambridge Mass., USA) and MSH6
(dilution 1:100, clone 44, Becton Dickinson, Lexington, MA, USA).
Statistical analysis
The distribution of chromosomes involved in missegregation
and rearrangements was tested by likelihood statistical modeling
according to [29], multiple gains being counted only once to avoid
bias. All statistical tests were two-tailed. Chi2 was used to test the
two-by-two associations between chromosome alterations using
Yates’ correction when necessary. In the comparison between MSI
and MSS tumors, all mean values were compared using Student t
test whereas the distribution of patient sex, tumor location and
tumor staging was tested using Chi2. For clustering analysis, data
were coded in binary form using ‘‘1’’ for AI and ‘‘21’’ for normal
informative locus. Different coding schemes were used but did not
give substantially different results. Data were clustered using a two-
way unsupervised clustering method, with uncentered correlation
as similarity metrics for both genes and subjects value vectors. The
average linkage was chosen as aggregation method. Computations
were run under Gene Cluster 3.0. Cluster trees were produced
using Java TreeView 1.0.4 (Eisen’s SoftwaresH).
Supporting Information
Table S1 Clinical, chromosomal and MSI data from 96 near-
diploid colorectal tumors Case, tumor number; * patients with
familial adenomatous polyposis; Age, patient’s age (years); Gender,
female (F) or male (M); A.C., Astler Coller staging; Loc, tumor
location: left (L), proximal (P), rectum (R), sigmoid (S) or unknown
(U); karyo, number of karyotypes established; Ch Nb, mean
number of chromosomes; MSI, microsatellite instability status:
instable (I), stable (S) or unknown (U)
Found at: doi:10.1371/journal.pone.0001632.s001 (0.04 MB PDF)
Table S2 Karyo-array of the tumors: involvement of individual
chromosomes in missegregations Chromosomes were coded as 2 if
present in normal status (i.e. two copies for all autosomes, for X
chromosome in females and one copy for X and Y chromosomes
in males), as 1 or 0 (blue background) if one or two homologs were
lost and as 3, 4 or 5 (red background) if one, two or three
supernumerary copies were found. Case, tumor number; losses,
number of whole-chromosome losses; gains, number of whole-
chromosome gains; MSG, missegregation i.e. total number of
whole-chromosomes losses and gains
Found at: doi:10.1371/journal.pone.0001632.s002 (0.05 MB PDF)
Table S3 Karyo-array of the tumors: involvement of individual
chromosomes in structural rearrangements and resulting chromo-
somal imbalances Chromosome arms were coded as 2 if present in
normal status (i.e. two copies for all autosomes, for X chromosome
in females and one copy for X and Y chromosomes in males), as 1
or 0 (blue background) if one or two copies copies were lost and as
3, 4 or 5 (red background) if one, two or three supernumerary
copies were found. Case, tumor number; Rea, total number of
rearranged chromosomes, a rearranged chromosome was counted
only once even if present in more than one copy; Bal, number of
balanced rearrangements; SR losses, number of chromosomal
losses resulting from structural rearrangements; SR gains, number
of chromosomal gains resulting from structural rearrangements,
multiple gains of one chromosome arm were counted only once; p,
short arm; q, long arm
Found at: doi:10.1371/journal.pone.0001632.s003 (0.07 MB PDF)
Table S4 Analysis of the two-by-two associations between 29
chromosomal imbalances in the sample of 96 near-diploid colorectal
tumors Observed (A) and theoretical (B) numbers of tumors that
display (above the diagonal) or not (below the diagonal) eachtwo-by-
two association. Theoretical values were calculated under the
hypothesis that associations occurred only by chance according to
the relative frequency of each alteration. In C are indicated in each
box the Chi2 values (cut-off value=3.84, p,0.05) testing the
observed number of tumors that display each association compared
to the theoretical value. Forty-five associations were observed more
frequently than expected by chance (positive associations), among
them associations between chromosomal losses (blue background),
chromosomal gains (pink background), or chromosomal gains and
losses (purple background) are distinguished, and 6 were too rarely
observed (negative associations, yellow background). NO: no object,
*theoretical value isinferiorto1. Thefirst row initalicsinB indicates
the frequency of each aberration.
Found at: doi:10.1371/journal.pone.0001632.s004 (0.12 MB PDF)
Figure S1 R-banding schematic karyotype indicating the
chromosomal imbalances resulting from the structural rearrange-
ments identified in our sample of 96 near-diploid colorectal
cancers. Red lines, gains; blue lines, losses; thick red lines, multiple
gains; dotted blue lines, deletions within a chromosomal region
that could not be accurately identified; numbers, case number.
Found at: doi:10.1371/journal.pone.0001632.s005 (0.09 MB PDF)
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